Kanwal F, Shubrook JH, Younossi Z, Natarajan Y, Bugianesi E, Rinella ME, Harrison SA, Mantzoros C, Pfotenhauer K, Klein S, Eckel RH, Kruger D, El-Serag H, Cusi K. Preparing for the NASH Epidemic: A Call to Action. Obesity. 2021 Sep;29(9):1401-1412. doi: 10.1002/oby.23250.
This article is being published jointly in Obesity: The Journal of the Obesity Society, Gastroenterology, Diabetes Care, and Metabolism: Clinical and Experimental.
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are common conditions with a rising burden. Yet there are significant management gaps between clinical guidelines and practice in patients with NAFLD and NASH.
In this publication participants reviewed and discussed:
- Published literature on global burden
- Risk stratification
- Management of individuals with NAFLD, including those with NASH
Participants identified promising approaches for clinical practice and prepared a comprehensive, unified strategy for primary care providers and relevant specialists encompassing the full spectrum of NAFLD and NASH care. They also identified specific high-yield targets for clinical research and called for a unified, international public health response to NAFLD and NASH.
Read the full article learn how to improve care for the growing population of patients with NAFLD and/or NASH.